Professor Jun Zhang got his Bachelor degree on Medicine in 1994 in Shanghai Medical School, and then he received three years’ training on epidemiology and was awarded with master degree in 1997. After then he worked in Xiamen University as faculty until now. In 2005, he and his colleagues founded National Institute of Diagnostics and Vaccine Development in infectious diseases (NIDVD) in Xiamen University. His researches focus on the virology, immunology and epidemiology of many human pathogens. As one of the leading scientists, he is deeply involved in the innovation and translation of hepatitis E vaccine, HPV vaccine, COVID-19 vaccine and many immunologic diagnostic reagents against infectious pathogens. Among them, Hepatitis E vaccine (Hecolin) and HPV 16/18 bivalent vaccine (Cecolin) had been launched in China; the nine-valent HPV vaccine are under Phase III clinical trial. He had published > 100 papers in peer reviewed journals.